GUIDED THERAPEUTICS INC (GTHP)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, GUIDED THERAPEUTICS INC reported revenue of $767.0K, up 10857.1% from the prior year. The company ran a net loss, with a net margin of -416.7% and a gross margin of 74.4%. It held $1.32M in total assets against $7.33M in total liabilities.
Key ratios (FY2025)
74.4%
Gross margin
-309.3%
Operating margin
-416.7%
Net margin
+10857.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $767.0K | $7.0K | $98.0K | $13.0K | $81.0K | $102.0K | $36.0K | $57.0K | $244.0K | $0 |
| Cost of Revenue | $196.0K | $5.0K | $62.0K | $81.0K | $61.0K | — | — | — | — | — |
| Gross Profit | $571.0K | $2.0K | $36.0K | -$68.0K | $20.0K | $143.0K | -$34.0K | -$32.0K | -$286.0K | $112.0K |
| Operating Income | -$2.37M | -$2.11M | -$3.46M | -$3.33M | -$2.36M | -$1.05M | -$937.0K | -$1.55M | -$3.12M | -$3.82M |
| Net Income | -$3.20M | -$2.42M | -$3.49M | -$4.34M | -$2.07M | -$279.0K | -$1.92M | $1.02M | -$10.70M | -$3.97M |
| EPS (Diluted) | $-0.04 | $-0.05 | $-0.07 | $-0.15 | $-0.18 | $-0.04 | $-0.58 | $0.01 | $0.00 | — |
| Total Assets | $1.32M | $1.38M | $1.67M | $3.37M | $2.04M | $1.35M | $1.18M | $236.0K | $406.0K | $1.49M |
| Total Liabilities | $7.33M | $6.27M | $5.47M | $6.25M | $7.49M | $12.21M | $18.11M | $16.06M | $19.81M | $10.76M |
| Shareholders' Equity | -$6.01M | -$4.89M | -$3.81M | -$2.88M | -$5.45M | -$10.86M | -$16.93M | -$15.82M | -$19.40M | -$9.27M |
| Cash & Equivalents | — | — | — | $2.31M | $643.0K | $182.0K | $899.0K | $0 | $1.0K | $14.0K |
| Operating Cash Flow | -$1.07M | -$1.12M | -$1.75M | -$1.48M | -$1.59M | -$1.88M | -$806.0K | -$1.36M | -$1.14M | -$1.80M |
| Capital Expenditures | $2.0K | $0 | $0 | $31.0K | $14.0K | $1.0K | $0 | — | — | — |
| Shares Outstanding | 86.15M | 65.13M | 54.10M | 48.60M | 13.67M | 13.14M | 3.3K | 2.7K | 62.0K | 669 |